Back

Oral anticoagulation regimen after left atrial appendage occlusion in elderly atrial fibrillation patients with versus without cardiovascular comorbidities

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Left atrial appendage closure: outcomes and evidence Left Atrial Appendage Closure ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Sanghamitra Mohanty

St. David's Medical Center, Austin (United States of America)

7 More presentations in this session

Presentation thumbnail
Efficacy and safety of left atrial appendage closure versus oral anticoagulation in atrial fibrillation: a two-part randomised-trial synthesis and a pooled analysis
Doctor H. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Left atrial appendage occlusion for atrial fibrillation–related stroke despite chronic oral anticoagulation
Mr L. Giovachini (Paris, FR)
Abstract Slides
Presentation thumbnail
Clinical utility of one-year transesophageal echocardiography after left atrial appendage closure: a tertiary care center experience
Doctor J. Veillette (Quebec, CA)
Abstract Slides Video
Presentation thumbnail
So happy together – acute and long-term safety and efficacy of concomitant pulsed field ablation of atrial fibrillation and left atrial appendage closure
Doctor D. Nair (Jonesboro, US)
Presentation thumbnail
Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: updated evidence from a systematic review and meta-analysis
Doctor C. Wang (Hangzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Left atrial appendage closure: outcomes and evidence

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Direct oral anticoagulants versus left atrial appendage closure in elderly patients (>80) with atrial fibrillation: results from a propensity matched analysis in real-life patients
28 August 2020
thumbnail
Webinar
Balancing stroke and bleeding risks in patients with AF and concomitant coronary artery disease, malignancy, chronic kidney disease, or frailty
10 November 2025
thumbnail
Congress Presentation
Oral anticoagulation monotherapy versus combination antithrombotic therapy in patients with AF and PCI with a drug-eluting stent implantation: a systematic review and meta-analysis
23 April 2026
thumbnail
Congress Presentation
Left atrial appendage occlusion with prior thrombus under OAC: feasibility and safety in a case series of patients with LA dilation and impaired atrial function
14 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources